Levophacetoperane (Lidépran, Phacétoperane) is a
psychostimulant developed by
Rhône-Poulenc
Rhône-Poulenc () was a French chemical and pharmaceutical company founded in 1928. In 1999 it merged with Hoechst AG to form Aventis. As of 2015, the pharmaceutical operations of Rhône-Poulenc are part of Sanofi and the chemicals divisions a ...
in the 1950s. The drug has been used as an
antidepressant and
anorectic
An anorectic or anorexic is a drug which reduces appetite, resulting in lower food consumption, leading to weight loss. By contrast, an appetite stimulant is referred to as orexigenic.
The term is (from the Greek ''ἀν-'' (an-) = "without" a ...
.
It is the reverse
ester
In chemistry, an ester is a compound derived from an oxoacid (organic or inorganic) in which at least one hydroxyl group () is replaced by an alkoxy group (), as in the substitution reaction of a carboxylic acid and an alcohol. Glycerides a ...
of
methylphenidate
Methylphenidate, sold under the brand names Ritalin and Concerta among others, is the most widely prescribed central nervous system (CNS) stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser exten ...
.
See also
*
Dexmethylphenidate
References
2-Benzylpiperidines
Acetate esters
Anorectics
Antidepressants
Norepinephrine–dopamine reuptake inhibitors
Phenylethanolamine ethers
Stimulants
2-Piperidinyl compounds
{{nervous-system-drug-stub